Impact of liver metastasis on immunotherapy in gastric carcinoma

doi:10.4240/wjgs.v16.i10.3084

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=0

Oct 27, 2024 (publication date) through Sep 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Surg. Oct 27, 2024; 16(10): 3084-3086
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3084

Impact of liver metastasis on immunotherapy in gastric carcinoma

Mushtaq Chalkoo, Mohd Yaqoob Bhat, Yaser Hussain Wani

Mushtaq Chalkoo, Department of Surgery, Government Medical College, Srinagar 190014, Jammu and Kashmir, India

Mohd Yaqoob Bhat, Department of General Surgery, Government Medical College Srinagar, Srinagar 190010, Jammu and Kashmir, India

Yaser Hussain Wani, Post Graduate Department of Minimal Access and General Surgery, Government Medical College Srinagar, Srinagar 190010, Jammu and Kashmīr, India

Co-first authors: Mushtaq Chalkoo and Yaser Hussain Wani.

Author contributions: Chalkoo M, Bhat MY, and Wani YH designed the study; Bhat MY performed the research and typing; Wani YH performed the typing and editing the manuscript as well as analyzed the data; All authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/

Corresponding author: Mohd Yaqoob Bhat, MBBS, MS, FNB Minimal Access Surgery Resident, Department of General Surgery, Government Medical College Srinagar, Kaksarai Karan Nagar, Srinagar 190010, Jammu and Kashmir, India. dryaqoob92@gmail.com

Received: March 19, 2024
Revised: May 24, 2024
Accepted: June 28, 2024
Published online: October 27, 2024
Processing time: 191 Days and 22.4 Hours

Core Tip

Core Tip: Liver metastasis affects the systemic immune response, reducing the efficacy of immunotherapy for gastric cancer patients with liver metastases. According to studies, the presence of liver metastases reduces the effectiveness of immunotherapy by lowering progression-free survival and objective response rates. Strategies such as liver-mediated radiation may aid in improving treatment outcomes. Understanding the intricate interplay between the two is crucial for offering the best possible treatment for stomach cancer with liver metastases.